Valion Bio

VBIO
CUSIP 888705308 COMMON STOCK
Reported in filings as: TIVIC HEALTH SYSTEMS INC

Institutional ownership · Q2 2026

Institutional holders 12 +4 (+50.0%) vs Q1 2026
Reported value $205.6K -11.9% vs Q1 2026
Shares held 398.1K +133.9K shares
Quarter Q2 2026 Period ended Jun 30, 2026

12 institutional managers reported holding 398,070 shares worth $205,603 on Form 13F for Q2 2026, against 8 in Q1 2026. Share positions on CUSIP 888705308 only; option legs and principal-amount lines are not counted.

Top 12 institutional holders · Q2 2026

Largest Q2 2026 Form 13F holders of CUSIP 888705308 by reported value
# Manager Shares Value % of portfolio Change Position page
1 Murchinson Ltd 115,000 $59.8K < 0.01% New Position
2 CITADEL ADVISORS LLC 74,145 $38.5K < 0.01% New Position
3 Sanctuary Advisors LLC 61,205 $31.8K < 0.01% — Position
4 Marex Group plc 54,287 $28.2K < 0.01% -5.0K Position
5 Virtu Financial LLC 39,225 $20.0K < 0.01% New Position
6 GEODE CAPITAL MANAGEMENT LLC 19,374 $10.1K < 0.01% -68.4K Position
7 UBS Group AG 11,094 $5.8K < 0.01% +8.7K Position
8 TWO SIGMA SECURITIES LLC 10,162 $5.3K < 0.01% New Position
9 HRT FINANCIAL LP 11,462 $5.0K < 0.01% -31.0K Position
10 Tower Research Capital LLC TRC 2,095 $1.1K < 0.01% +1.5K Position
11 SBI Securities Co Ltd 16 $8 < 0.01% — Position
12 TD Waterhouse Canada Inc 5 $2 < 0.01% New Position

Values as reported on each manager's Q2 2026 Form 13F. Change is in shares against the manager's prior-quarter filing.

13F holders by quarter

Form 13F holders of CUSIP 888705308 by quarter
Quarter Holders Shares Value
Q2 2026 12 +4 398.1K $205.6K
Q1 2026 8 +1 264.2K $233.4K
Q4 2025 7 81.9K $118.8K
Q3 2025 7 +3 196.2K $567.1K
Q2 2025 4 +2 45.0K $186.6K
Q1 2025 2 21 $54

Q1 2025–Q2 2026, as reported on Form 13F.

Fund holders · N-PORT

1 fund
Largest fund holders of CUSIP 888705308 reported on Form N-PORT
Fund Value % of fund As of
Fidelity Extended Market Index Fund $38.6K < 0.01% May 2026

1 fund reported holding $38,562 in total on their latest public Form N-PORT reports, the most recent dated May 2026.

Insiders · Form 4

Net insider transactions, 12 months +$28.4K 2 filings with purchases ($28.4K), 0 filings with sales ($0)
Latest filings
All Valion Bio insider filings

5%+ holders · 13D/G

2 filers
Schedule 13D and 13G filers reporting a stake in CUSIP 888705308
Filer % of class Filed
3i LP 13D 9.9% 2026-08-20
Murchinson Ltd 13G 10.0% 2026-07-17

Latest Schedule 13D or 13G from each filer naming this CUSIP; stakes a filer has reported closed are left out.

Annual & quarterly reports

  • 10-K · FY2025 Filed 2026-03-30
    Business · Risk Factors · Management's Discussion and Analysis
All Valion Bio SEC filings

Federal lobbying

Spend, trailing 12 months $20.0K Through Q3 2026, from quarterly LD-2 reports
Valion Bio lobbying profile

Ownership explorer

Loading ownership explorer…

Security Details

CUSIP 888705308
Symbol VBIO
Type Common stock
Class COM as filed on 13F
Company Valion Bio

Other securities from this issuer

Name Symbol CUSIP Type
TIVIC HEALTH SYSTEMS INC TIVC 888705209 Common stock

Identifier History

Type Value From To
CUSIP 888705308 2026-03-31 Current

Listing History

Symbol Exchange From To
VBIO US 2026-06-01 Current